SNXFX
Price
$129.64
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VTSAX
Price
$143.16
Change
-$0.98 (-0.68%)
Updated
Nov 14 closing price
Ad is loading...

SNXFX vs VTSAX

Header iconSNXFX vs VTSAX Comparison
Open Charts SNXFX vs VTSAXBanner chart's image
Schwab 1000 Index®
Price$129.64
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$143.16
Change-$0.98 (-0.68%)
VolumeN/A
CapitalizationN/A
SNXFX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SNXFX vs. VTSAX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNXFX is a Buy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. SNXFX (18.3B). VTSAX pays higher dividends than SNXFX: VTSAX (1.35) vs SNXFX (1.28). SNXFX was incepted earlier than VTSAX: SNXFX (34 years) vs VTSAX (24 years). SNXFX is a more actively managed with annual turnover of: 3.00 vs. VTSAX (2.00). SNXFX has a lower initial minimum investment than VTSAX: SNXFX (0) vs VTSAX (3000). SNXFX annual gain was more profitable for investors over the last year : 35.41 vs. VTSAX (33.39). SNXFX return over 5 years is better than : 92.08 vs. VTSAX (87.46).
SNXFXVTSAXSNXFX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence34 years24 years-
Gain YTD26.66824.891107%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets18.3B1.73T1%
Annual Yield % from dividends1.281.3595%
Returns for 1 year35.4133.39106%
Returns for 3 years27.4422.82120%
Returns for 5 years92.0887.46105%
Returns for 10 years150.59194.0778%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals